Key result
Pro-active risk-guided management in chest pain clinics lowers absolute CV risk by ~3 percentage points.
Why the study?
To evaluate whether a pro-active, absolute cardiovascular risk-guided approach could opportunistically modify cardiovascular risk factors in patients presenting to a chest pain clinic without coronary ischaemia.
Does a pro-active, absolute cardiovascular risk-guided approach improve 5-year absolute cardiovascular risk scores in patients without coronary ischaemia attending a chest pain clinic?
RCT (n=189)
open label, blinded endpoint
randomised
No
Does a pro-active, absolute cardiovascular risk-guided approach improve 5-year absolute cardiovascular risk scores in patients without coronary ischaemia attending a chest pain clinic?
An opportunistic, absolute cardiovascular risk-guided management strategy in a chest pain clinic significantly improved 5-year absolute cardiovascular risk scores compared to standard care.
Answers are grounded in this paper and cite their sources.
Supports proactive risk-guided care in chest pain clinics; extends absolute CV risk strategies to evaluated patients without ischaemia.
OBJECTIVES: To assess the efficacy of a pro-active, absolute cardiovascular risk-guided approach to opportunistically modifying cardiovascular risk factors in patients without coronary ischaemia attending a chest pain clinic. DESIGN: Prospective, randomised, open label, blinded endpoint study. SETTING: The rapid access chest pain clinic of Royal Hobart Hospital, a tertiary hospital. PARTICIPANTS: Patients who presented to the chest pain clinic between 1 July 2014 and 31 December 2017 who had intermediate to high absolute cardiovascular risk scores (5-year risk ≥ 8%). Patients with known cardiac disease or from groups with clinically determined high risk of cardiovascular disease were excluded. MAIN OUTCOME MEASURES: The primary endpoint was change in 5-year absolute risk score (Australian absolute risk calculator) at follow-up (at least 12 months after baseline assessment). Secondary endpoints were changes in lipid profile, blood pressure, smoking status, and body mass index, and major adverse cardiovascular events. RESULTS: The mean change in risk at follow-up was +0.4 percentage points (95% CI, -0.8 to 1.5 percentage points) for the 98 control group patients and -2.4 percentage points (95% CI, -1.5 to -3.4 percentage points) for the 91 intervention group patients; the between-group difference in change was 2.7 percentage points (95% CI, 1.2-4.1 percentage points). Mean changes in lipid profile, systolic blood pressure, and smoking status were larger for the intervention group, but not statistically different from those for the control group. CONCLUSIONS: An absolute cardiovascular risk-guided, pro-active risk factor management strategy employed opportunistically in a chest pain clinic significantly improved 5-year absolute cardiovascular risk scores. TRIAL REGISTRATION: Australia New Zealand Clinical Trial Registry, ACTRN12617000615381 (retrospective).
No takes yet. Share an insight, caveat, or question.
Black et al. (2021) conducted an RCT in patients without coronary ischaemia attending a chest pain clinic (n=189). pro-active, absolute cardiovascular risk-guided approach to modifying risk factors vs. control group was evaluated on change in 5-year absolute risk score at follow-up (difference 2.7 percentage points, 95% CI 1.2-4.1). A pro-active, absolute cardiovascular risk-guided management strategy in a chest pain clinic improved 5-year absolute cardiovascular risk scores by 2.7 percentage points.
Synapse has enriched 10 related papers. Consider them for comparative context: